{"title":"抗生素不良事件的管理","authors":"Toshiharu Urakami, Takashi Matono","doi":"10.1016/j.jiac.2025.102735","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Antibiotic-associated adverse drug events (ADEs) are common and diverse in clinical practice, yet healthcare professionals often lack sufficient understanding of them. An ill-considered change to an alternative agent whent symptoms of suspected ADEs appear can lead to excessive overuse and misuse of antibiotics. Proper management of ADEs is part of antimicrobial stewardship.</div></div><div><h3>Areas covered</h3><div>This review describes clinical characteristics, diagnosis and management of ADEs, featuring drug fever, rash, nephrotoxicity, liver injury, interstitial pneumonitis, rhabdomyolysis, encephalopathy, QT prolongation, thrombocytopenia and neutropenia.</div></div><div><h3>Summary</h3><div>Healthcare professionals should be familiar with the typical symptoms, time course and likely causative agent for each adverse reaction. Early detection and proper judgement are important. In sever case, early discontinuation of the causative agent and proper treatment are required. If it is not fatal, continuing the suspected agent and careful monitoring may help identify the causative agent. Especially in penicillin allergies, it is important to remember that most patients labeled as allergic are, in fact, misclassified.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 7","pages":"Article 102735"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of antibiotic adverse events\",\"authors\":\"Toshiharu Urakami, Takashi Matono\",\"doi\":\"10.1016/j.jiac.2025.102735\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>Antibiotic-associated adverse drug events (ADEs) are common and diverse in clinical practice, yet healthcare professionals often lack sufficient understanding of them. An ill-considered change to an alternative agent whent symptoms of suspected ADEs appear can lead to excessive overuse and misuse of antibiotics. Proper management of ADEs is part of antimicrobial stewardship.</div></div><div><h3>Areas covered</h3><div>This review describes clinical characteristics, diagnosis and management of ADEs, featuring drug fever, rash, nephrotoxicity, liver injury, interstitial pneumonitis, rhabdomyolysis, encephalopathy, QT prolongation, thrombocytopenia and neutropenia.</div></div><div><h3>Summary</h3><div>Healthcare professionals should be familiar with the typical symptoms, time course and likely causative agent for each adverse reaction. Early detection and proper judgement are important. In sever case, early discontinuation of the causative agent and proper treatment are required. If it is not fatal, continuing the suspected agent and careful monitoring may help identify the causative agent. Especially in penicillin allergies, it is important to remember that most patients labeled as allergic are, in fact, misclassified.</div></div>\",\"PeriodicalId\":16103,\"journal\":{\"name\":\"Journal of Infection and Chemotherapy\",\"volume\":\"31 7\",\"pages\":\"Article 102735\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-05-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1341321X25001321\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25001321","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Antibiotic-associated adverse drug events (ADEs) are common and diverse in clinical practice, yet healthcare professionals often lack sufficient understanding of them. An ill-considered change to an alternative agent whent symptoms of suspected ADEs appear can lead to excessive overuse and misuse of antibiotics. Proper management of ADEs is part of antimicrobial stewardship.
Areas covered
This review describes clinical characteristics, diagnosis and management of ADEs, featuring drug fever, rash, nephrotoxicity, liver injury, interstitial pneumonitis, rhabdomyolysis, encephalopathy, QT prolongation, thrombocytopenia and neutropenia.
Summary
Healthcare professionals should be familiar with the typical symptoms, time course and likely causative agent for each adverse reaction. Early detection and proper judgement are important. In sever case, early discontinuation of the causative agent and proper treatment are required. If it is not fatal, continuing the suspected agent and careful monitoring may help identify the causative agent. Especially in penicillin allergies, it is important to remember that most patients labeled as allergic are, in fact, misclassified.
期刊介绍:
The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.